Disc Medicine, Inc. (IRON) — Institutional Holders, Q2 2026
218 institutional investment managers reported a IRON position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $3.1B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1 to 100. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
IRON in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Vestal Point CapitalAdded · +850,000 sh+$62.2M
- JPMORGAN CHASEAdded · +504,315 sh+$36.9M
- Opaleye ManagementAdded · +434,000 sh+$31.7M
- PRICE T ROWE ASSOCIATESAdded · +326,049 sh+$23.8M
- Logos Global ManagementAdded · +315,000 sh+$23.0M
Biggest sellers
- ORBIMED ADVISORSTrimmed · -710,015 sh-$51.9M
- FMRTrimmed · -692,421 sh-$50.6M
- GOLDMAN SACHS GROUPTrimmed · -542,459 sh-$39.7M
- JENNISON ASSOCIATESTrimmed · -170,862 sh-$12.5M
- Integral Health Asset ManagementSold out · -170,000 sh-$12.4M
IRON 13F holders ranked 1–100 of 218
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | FMR#1 · 4,894,473 sh | 4,894,473 | $358.0M | 0.02% | -12.4% |
| 2 | BlackRock#2 · 2,467,899 sh | 2,467,899 | $180.5M | <0.01% | +8.5% |
| 3 | RA CAPITAL MANAGEMENT, L.P.#3 · 2,450,221 sh | 2,450,221 | $179.2M | 1.56% | 0.0% |
| 4 | JPMORGAN CHASE#4 · 1,875,795 sh | 1,875,795 | $139.9M | <0.01% | +36.8% |
| 5 | PRICE T ROWE ASSOCIATES#5 · 1,875,399 sh | 1,875,399 | $137.2M | 0.01% | +21.0% |
| 6 | WELLINGTON MANAGEMENT GROUP LLP#6 · 1,741,351 sh | 1,741,351 | $127.4M | 0.02% | +0.3% |
| 7 | STATE STREET#7 · 1,648,836 sh | 1,648,836 | $120.6M | <0.01% | -2.9% |
| 8 | Vestal Point Capital#8 · 1,550,000 sh | 1,550,000 | $113.4M | 2.65% | +121.4% |
| 9 | Atlas Venture Life Science Advisors#9 · 1,513,875 sh | 1,513,875 | $110.7M | 12.56% | 0.0% |
| 10 | VANGUARD CAPITAL MANAGEMENT#10 · 1,369,027 sh | 1,369,027 | $100.1M | <0.01% | -0.5% |
| 11 | Frazier Life Sciences Management, L.P.#11 · 1,354,852 sh | 1,354,852 | $99.1M | 2.16% | 0.0% |
| 12 | TCG Crossover Management#12 · 1,341,862 sh | 1,341,862 | $98.1M | 2.36% | 0.0% |
| 13 | BVF#13 · 1,153,612 sh | 1,153,612 | $84.4M | 2.16% | -9.3% |
| 14 | Woodline Partners#14 · 958,281 sh | 958,281 | $70.1M | 0.22% | 0.0% |
| 15 | Siren, L.L.C.#15 · 888,401 sh | 888,401 | $65.0M | 1.31% | -10.1% |
| 16 | Logos Global Management#16 · 875,000 sh | 875,000 | $64.0M | 2.75% | +56.2% |
| 17 | Opaleye Management#17 · 855,000 sh | 855,000 | $62.5M | 5.66% | +103.1% |
| 18 | GEODE CAPITAL MANAGEMENT#18 · 789,724 sh | 789,724 | $57.8M | <0.01% | +6.1% |
| 19 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)#19 · 657,000 sh | 657,000 | $48.1M | 0.50% | 0.0% |
| 20 | DIMENSIONAL FUND ADVISORS#20 · 569,018 sh | 569,018 | $41.6M | <0.01% | +44.3% |
| 21 | Bellevue Group AG#21 · 560,000 sh | 560,000 | $41.0M | 0.86% | +21.9% |
| 22 | Saturn V Capital Management#22 · 524,730 sh | 524,730 | $38.4M | 5.50% | +16.6% |
| 23 | ARMISTICE CAPITAL#23 · 460,000 sh | 460,000 | $33.6M | 0.41% | -14.2% |
| 24 | JENNISON ASSOCIATES#24 · 439,520 sh | 439,520 | $32.1M | 0.02% | -28.0% |
| 25 | abrdn plc#25 · 438,174 sh | 438,174 | $32.0M | 0.04% | +16.7% |
| 26 | Palo Alto Investors#26 · 416,646 sh | 416,646 | $30.5M | 4.21% | +3.7% |
| 27 | EVENTIDE ASSET MANAGEMENT#27 · 395,651 sh | 395,651 | $28.9M | 0.39% | 0.0% |
| 28 | Pictet Asset Management Holding SA#28 · 385,375 sh | 385,375 | $28.2M | 0.03% | -0.4% |
| 29 | Assenagon Asset Management S.A.#29 · 384,158 sh | 384,158 | $28.1M | — | -29.7% |
| 30 | LOOMIS SAYLES & L P#30 · 381,864 sh | 381,864 | $27.9M | 0.04% | +20.4% |
| 31 | Foresite Capital Management V#31 · 374,069 sh | 374,069 | $27.4M | 7.55% | 0.0% |
| 32 | ORBIMED ADVISORS#32 · 357,535 sh | 357,535 | $26.2M | 0.48% | -66.5% |
| 33 | BAKER BROS. ADVISORS#33 · 349,657 sh | 349,657 | $25.6M | 0.13% | 0.0% |
| 34 | VANGUARD PORTFOLIO MANAGEMENT#34 · 281,937 sh | 281,937 | $20.6M | <0.01% | +14.0% |
| 35 | Octagon Capital Advisors#35 · 270,000 sh | 270,000 | $19.7M | 1.77% | 0.0% |
| 36 | NORTHERN#36 · 264,990 sh | 264,990 | $19.4M | <0.01% | +7.2% |
| 37 | CHARLES SCHWAB INVESTMENT MANAGEMENT#37 · 257,382 sh | 257,382 | $18.8M | <0.01% | +2.5% |
| 38 | Checkpoint Capital L.P.#38 · 240,125 sh | 240,125 | $17.6M | 4.51% | -16.2% |
| 39 | VANGUARD FIDUCIARY#39 · 225,198 sh | 225,198 | $16.5M | <0.01% | +3.6% |
| 40 | CITADEL ADVISORS#40 · 209,308 sh | 209,308 | $15.3M | <0.01% | +113.7% |
| 41 | Bank of New York Mellon#41 · 204,727 sh | 204,727 | $15.0M | <0.01% | -0.1% |
| 42 | BNP PARIBAS FINANCIAL MARKETS#42 · 184,695 sh | 184,695 | $13.5M | <0.01% | +44.6% |
| 43 | Catalio Capital Management#43 · 159,384 sh | 159,384 | $11.7M | 2.19% | +29.6% |
| 44 | Sofinnova Ventures#44 · 146,239 sh | 146,239 | $10.7M | 0.55% | +86.7% |
| 45 | Bain Capital Life Sciences Investors#45 · 141,234 sh | 141,234 | $10.3M | 0.61% | 0.0% |
| 46 | TWO SIGMA INVESTMENTS#46 · 136,750 sh | 136,750 | $10.0M | <0.01% | New |
| 47 | BANK OF AMERICA#47 · 135,111 sh | 135,111 | $9.9M | <0.01% | -19.0% |
| 48 | Alyeska Investment Group, L.P.#48 · 125,000 sh | 125,000 | $9.1M | 0.02% | 0.0% |
| 49 | Ensign Peak Advisors#49 · 122,111 sh | 122,111 | $8.9M | 0.01% | -36.2% |
| 50 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME#50 · 114,109 sh | 114,109 | $8.3M | <0.01% | +2.9% |
| 51 | UBS Group AG#51 · 110,971 sh | 110,971 | $8.1M | <0.01% | +12.5% |
| 52 | Trexquant Investment#52 · 107,699 sh | 107,699 | $7.9M | 0.05% | New |
| 53 | KENNEDY CAPITAL MANAGEMENT#53 · 106,769 sh | 106,769 | $7.8M | 0.14% | -1.4% |
| 54 | MILLENNIUM MANAGEMENT#54 · 106,248 sh | 106,248 | $7.8M | <0.01% | +27.6% |
| 55 | GOLDMAN SACHS GROUP#55 · 97,383 sh | 97,383 | $7.1M | <0.01% | -84.8% |
| 56 | MORGAN STANLEY#56 · 91,595 sh | 91,595 | $6.7M | <0.01% | -2.8% |
| 57 | HRT FINANCIAL#57 · 90,822 sh | 90,822 | $6.6M | 0.02% | New |
| 58 | SILVERARC CAPITAL MANAGEMENT#58 · 82,800 sh | 82,800 | $6.1M | 0.63% | -57.8% |
| 59 | RAYMOND JAMES FINANCIAL#59 · 77,980 sh | 77,980 | $5.7M | <0.01% | +74.5% |
| 60 | Squarepoint Ops#60 · 75,872 sh | 75,872 | $5.5M | <0.01% | +139.3% |
| 61 | DnB Asset Management AS#61 · 73,127 sh | 73,127 | $5.3M | 0.01% | -24.4% |
| 62 | iA Global Asset Management#62 · 66,023 sh | 66,023 | $4.8M | 0.06% | -0.3% |
| 63 | Casdin Capital#63 · 65,000 sh | 65,000 | $4.8M | 0.24% | 0.0% |
| 64 | SPHERA FUNDS MANAGEMENT LTD.#64 · 63,538 sh | 63,538 | $4.6M | 0.61% | +18.7% |
| 65 | Nuveen#65 · 60,357 sh | 60,357 | $4.4M | <0.01% | +17.5% |
| 66 | KVP Capital Advisors#66 · 58,250 sh | 58,250 | $4.3M | 3.13% | 0.0% |
| 67 | MOORE CAPITAL MANAGEMENT#67 · 57,796 sh | 57,796 | $4.2M | 0.06% | 0.0% |
| 68 | XTX Topco Ltd#68 · 56,710 sh | 56,710 | $4.1M | 0.05% | +64.8% |
| 69 | NEXTBio Capital Management#69 · 52,655 sh | 52,655 | $3.9M | 1.77% | 0.0% |
| 70 | ALGERT GLOBAL#70 · 51,850 sh | 51,850 | $3.8M | 0.04% | +128.6% |
| 71 | ExodusPoint Capital Management#71 · 51,623 sh | 51,623 | $3.8M | 0.02% | New |
| 72 | SCHRODER INVESTMENT MANAGEMENT GROUP#72 · 50,000 sh | 50,000 | $3.7M | <0.01% | -1.9% |
| 73 | Burkehill Global Management#73 · 50,000 sh | 50,000 | $3.7M | 0.13% | 0.0% |
| 74 | Brevan Howard Capital Management#74 · 49,996 sh | 49,996 | $3.7M | 0.03% | +54.3% |
| 75 | Swiss National Bank#75 · 49,800 sh | 49,800 | $3.6M | <0.01% | +3.8% |
| 76 | AMERIPRISE FINANCIAL#76 · 45,874 sh | 45,874 | $3.4M | <0.01% | +0.1% |
| 77 | HealthInvest Partners AB#77 · 43,682 sh | 43,682 | $3.2M | 0.86% | -59.3% |
| 78 | Quadrature Capital Ltd#78 · 42,419 sh | 42,419 | $3.1M | 0.03% | New |
| 79 | Invesco Ltd.#79 · 42,057 sh | 42,057 | $3.1M | <0.01% | +37.3% |
| 80 | ALPS ADVISORS#80 · 38,565 sh | 38,565 | $2.8M | 0.01% | +24.2% |
| 81 | CITIGROUP#81 · 38,317 sh | 38,317 | $2.8M | <0.01% | +394.9% |
| 82 | BNP Paribas Asset Management Holding S.A.#82 · 38,262 sh | 38,262 | $2.8M | <0.01% | -4.1% |
| 83 | Universal- Beteiligungs- und Servicegesellschaft mbH#83 · 36,634 sh | 36,634 | $2.7M | <0.01% | -3.6% |
| 84 | RHUMBLINE ADVISERS#84 · 35,844 sh | 35,844 | $2.6M | <0.01% | +8.4% |
| 85 | LAZARD ASSET MANAGEMENT#85 · 35,034 sh | 35,034 | $2.6M | <0.01% | -11.1% |
| 86 | SEVEN GRAND MANAGERS#86 · 35,000 sh | 35,000 | $2.6M | 0.10% | 0.0% |
| 87 | MARSHALL WACE, LLP#87 · 34,394 sh | 34,394 | $2.5M | <0.01% | New |
| 88 | Jump Financial#88 · 32,549 sh | 32,549 | $2.4M | 0.02% | -60.2% |
| 89 | BANK OF MONTREAL#89 · 32,308 sh | 32,308 | $2.4M | <0.01% | +12.3% |
| 90 | DEUTSCHE BANK AG\#90 · 30,643 sh | 30,643 | $2.2M | <0.01% | +25.6% |
| 91 | ALLIANCEBERNSTEIN L.P.#91 · 34,670 sh | 34,670 | $2.2M | <0.01% | +41.3% |
| 92 | RTW INVESTMENTS#92 · 30,000 sh | 30,000 | $2.2M | 0.02% | 0.0% |
| 93 | VICTORY CAPITAL MANAGEMENT#93 · 29,117 sh | 29,117 | $2.1M | <0.01% | -0.3% |
| 94 | WELLS FARGO & COMPANY#94 · 28,924 sh | 28,924 | $2.1M | <0.01% | +96.9% |
| 95 | TUDOR INVESTMENT ET AL#95 · 28,663 sh | 28,663 | $2.1M | <0.01% | -7.5% |
| 96 | MANUFACTURERS LIFE INSURANCE COMPANY, THE#96 · 27,771 sh | 27,771 | $2.0M | <0.01% | -14.5% |
| 97 | Y-Intercept (Hong Kong) Ltd#97 · 26,888 sh | 26,888 | $2.0M | — | New |
| 98 | Rafferty Asset Management#98 · 26,566 sh | 26,566 | $1.9M | <0.01% | -50.7% |
| 99 | Campbell & Investment Adviser#99 · 25,568 sh | 25,568 | $1.9M | 0.10% | New |
| 100 | PNC FINANCIAL SERVICES GROUP#100 · 22,333 sh | 22,333 | $1.6M | <0.01% | -11.7% |
Funds that sold out of IRON in Q2 2026 (23)
Held IRON at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.